Loading clinical trials...

Clinical Characteristics and Molecular Mechanism of Patients With Obstructive Sleep Apnea | Clinical Trials | Clareo Health

RECRUITING

Clinical Characteristics and Molecular Mechanism of Patients With Obstructive Sleep Apnea

NCT07277608•Capital Medical University

View on ClinicalTrials.gov

Summary

To clarify the clinical features of patients with obstructive sleep apnea; To construct a multi-omics database of patients with obstructive sleep apnea, and compare the effects of different degrees of sleep apnea on prognosis, immunity, and metabolism. The medium and long-term prognosis, complications, comorbidities, risk factors, and immune and metabolic dynamics of patients with sleep apnea after treatment were studied. To elucidate the biomarkers and therapeutic targets associated with obstructive sleep apnea.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patients with suspected obstructive sleep apnea (OSA) admitted to the sleep center of the respiratory Department of Beijing Chaoyang Hospital, Capital Medical University.
•Volunteer to participate in the study and sign an informed consent, and can complete at least 1 year of follow-up.

Exclusion Criteria

•Patients with obstructive sleep apnea who have been treated with impermanent positive pressure ventilation;
•Pregnant or lactating women;
•Patients with severe respiratory failure requiring mechanical ventilation;
•Patients with severe heart, lung, liver, kidney, and central nervous system damage;
•Refuse to participate in follow-up visits and/or take biological samples.

Locations (1)

Beijing Chaoyang hospital affiliated to Capital Medical University

Beijing, Beijing Municipality, China

Key Dates

Start Date

August 7, 2023

Primary Completion Date

August 7, 2033

Completion Date

August 7, 2033

Last Updated

December 11, 2025

Enrollment

500

ESTIMATED participants

Conditions

Obstructive Sleep Apnea

Contacts

Zhiling Zhao

CONTACT

+86 186 1280 8859 cysleep@163.com

OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

NCT06430957

Obstructive Sleep Apnea Risk ManagementPostoperative Complications+2 more

View study

RECRUITINGNA

Digital-supported Orofacial Myofunctional Therapy in OSA

NCT07292922

Obstructive Sleep Apnea (OSA)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 11, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Clinical Characteristics and Molecular Mechanism of Patients With Obstructive Sleep Apnea

Inclusion Criteria

Exclusion Criteria

OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

Digital-supported Orofacial Myofunctional Therapy in OSA

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

A Cross-sectional Study Examining Adipose Tissue in Obstructive Sleep Apnea

Diaphragm Ultrasound İn Children With OSAS

BodySleep Algorithm for OSA Diagnosis in Children